1-6 of 6
eculizumab
Close
Sort by
Journal Articles

Is there a role for immunosuppression in antiphospholipid syndrome?

Ecem Sevim, Rohan Willis, Doruk Erkan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 426–432.
https://doi.org/10.1182/hematology.2019000073
Published: 2019
Journal Articles

Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria

Samuel A. Merrill, Robert A. Brodsky
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 371–376.
https://doi.org/10.1182/asheducation-2018.1.371
Published: 2018
Journal Articles

Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria

Charles J. Parker
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 208–216.
https://doi.org/10.1182/asheducation-2016.1.208
Published: 2016
Journal Articles

Management of Paroxysmal Nocturnal Hemoglobinuria in the Era of Complement Inhibitory Therapy

Charles J. Parker
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 21–29.
https://doi.org/10.1182/asheducation-2011.1.21
Published: 2011
Journal Articles

Which Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Should Be Treated with Eculizumab?

Richard L. Haspel, Peter Hillmen
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 35.
https://doi.org/10.1182/asheducation-2008.1.35
Published: 2008
Journal Articles

The Role of Complement Inhibition in PNH

Peter Hillmen
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 116–123.
https://doi.org/10.1182/asheducation-2008.1.116
Published: 2008